H3P10 |
|
H3 histone pseudogene 10
|
|
|
0.350 |
0.846 |
DMBT1 |
Q9UGM3
|
deleted in malignant brain tumors 1
|
Enzyme
|
4.5E-63 |
0.533 |
0.654 |
MMP9 |
P14780
|
matrix metallopeptidase 9
|
Enzyme
|
1.9E-17 |
0.305 |
0.923 |
MPO |
P05164
|
myeloperoxidase
|
Enzyme
|
7.1E-15 |
0.377 |
0.923 |
RBL1 |
P28749
|
RB transcriptional corepressor like 1
|
Nucleic acid binding
|
2.9E-12 |
0.666 |
0.385 |
RBM45 |
Q8IUH3
|
RNA binding motif protein 45
|
|
2.1E-10 |
0.383 |
0.846 |
CDC6 |
Q99741
|
cell division cycle 6
|
|
1.1E-09 |
0.552 |
0.731 |
NQO1 |
P15559
|
NAD(P)H quinone dehydrogenase 1
|
|
1.2E-09 |
0.434 |
0.885 |
TLR4 |
O00206
|
toll like receptor 4
|
|
4.6E-09 |
0.321 |
0.962 |
EPCAM |
P16422
|
epithelial cell adhesion molecule
|
|
1.3E-07 |
0.451 |
0.885 |
CD44 |
P16070
|
CD44 molecule (Indian blood group)
|
|
2.4E-07 |
0.363 |
0.962 |
PIK3CG |
P48736
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
|
Kinase
|
1.4E-06 |
0.320 |
0.885 |
VEGFA |
P15692
|
vascular endothelial growth factor A
|
Signaling
|
2.4E-05 |
0.266 |
0.923 |
MLH1 |
P40692
|
mutL homolog 1
|
Nucleic acid binding
|
3.4E-05 |
0.399 |
0.808 |
EPB41L3 |
Q9Y2J2
|
erythrocyte membrane protein band 4.1 like 3
|
|
4.3E-05 |
0.619 |
0.615 |
GSTT1 |
P30711
|
glutathione S-transferase theta 1
|
|
1.5E-04 |
0.393 |
0.923 |
GRAP2 |
O75791
|
GRB2 related adaptor protein 2
|
|
1.5E-04 |
0.394 |
0.923 |
IL1A |
P01583
|
interleukin 1 alpha
|
|
1.6E-04 |
0.333 |
0.962 |
CXCL8 |
P10145
|
C-X-C motif chemokine ligand 8
|
Signaling
|
2.7E-04 |
0.310 |
0.962 |
PDPN |
Q86YL7
|
podoplanin
|
|
3.2E-04 |
0.470 |
0.769 |
CIB1 |
Q99828
|
calcium and integrin binding 1
|
|
3.3E-04 |
0.458 |
0.769 |
FOXM1 |
Q08050
|
forkhead box M1
|
|
7.4E-04 |
0.441 |
0.769 |
KRAS |
P01116
|
KRAS proto-oncogene, GTPase
|
Enzyme modulator
|
7.9E-04 |
0.320 |
0.923 |
HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |
DUT |
P33316
|
deoxyuridine triphosphatase
|
Enzyme
|
1.3E-03 |
0.678 |
0.615 |